Back to MORGAN STANLEY MORGAN STANLEY

NRIXNRIX
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NURIX THERAPEUTICS INC

MORGAN STANLEY holds 4.8M shares of NRIX (NURIX THERAPEUTICS INC), worth $115.5M as of 2026-Q2. The position was decreased (-3.4% shares). NRIX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$115.5M

Current Shares

4.8M

Total Value Change

+$73.3M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.8M
-3.4%
$115.5M0.0%$24.26
0
2026-Q1
Increased
4.9M
+1.0%
$76.4M0.0%$15.81
30
2025-Q4
Increased
4.9M
+115.9%
$92.6M0.0%$19.02
48
2025-Q3
Increased
2.3M
+4.3%
$20.9M0.0%$9.28
30
2025-Q2
Increased
2.2M
+47.7%
$24.7M0.0%$11.64
39
2025-Q1
Decreased
1.5M
-6.3%
$17.4M0.0%$12.15
0
2024-Q4
Decreased
1.6M
-16.7%
$29.5M0.0%$18.64
0
2024-Q3
Decreased
1.9M
-5.6%
$42.2M0.0%$23.05
0

Other major holders of NRIX: BlackRock, Inc., FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used